Biogen, in collaboration with the Massachusetts General Hospital (MGH) Department of Neurology, the MGH Neurological Clinical Research Institute (NCRI) and the Mass General Bio-Statistics Center, has established The Anne B. Young Neuroscience Translational Medicine Fellowship.
The two-year, clinician scientist program is open to neurologists and psychiatrists who will receive an exceptional training experience for drug development, capitalizing on the expertise of those at Biogen and MGH. Applications from other institutions are encouraged.
The program objective is to train clinician-scientists to rapidly and efficiently translate advances in neuroscience, neuropsychiatry, and cognition into treatments for people with neurological disorders and psychiatric disease.
The awardee will learn about the entire life cycle of therapy development from both industry and academic perspectives. This includes, but is not limited to, therapy selection, biomarker development, trial design, operations and regulatory science. This didactic, hands-on training program will increase the number of well-trained clinical investigators who are passionate about drug development in the neurosciences.
Each awardee will develop a research project under the guidance of a mentoring committee that includes at least one Biogen and one Mass General mentor. Awardees are expected to present their work in regular meetings and to publish results of their research in peer-review journals. Awardees will spend time at both Biogen and Mass General Hospital.
The program provides annual salary support commensurate with experience plus fringe benefits.
Applications for the position starting July of each year are due by November 1 the year prior. The application must include the following:
Applications will be treated as confidential.
Please submit your application by email, in PDF format, to the MGH Program Coordinator, Joanna Richards firstname.lastname@example.org.